Role of CYP2E1 in the Progression to NASH

CYP2E1 在 NASH 进展中的作用

基本信息

  • 批准号:
    7901161
  • 负责人:
  • 金额:
    $ 33.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-05-15 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In nonalcoholic fatty liver disease (NAFLD) the cellular signals that initiate hepatocyte lipid accumulation and progression from benign steatosis to hepatocyte injury and chronic liver disease are unknown. Both experimental and human NAFLD are associated with hepatic oxidative stress along with overexpression of prooxidant cytochrome P450 (CYP) enzymes. Our general hypothesis has been that oxidative stress in this disease alters cell signaling cascades that promote the development of hepatocyte injury. Investigations over the past funding period have defined effects of oxidative stress on mitogen-activated protein kinases (MARK) that regulate hepatocyte injury and death. Other studies have demonstrated that oxidative stress generated by CYP2E1 overexpression alters hepatic metabolism including insulin sensitivity and lipid accumulation. Based on these studies and additional preliminary data, our central hypothesis is that overactivation of MAPK signaling by chronic oxidative stress is a critical mechanism in the development of both hepatic steatosis and injury. We propose to test this hypothesis with studies in hepatocyte and in vivo models of steatosis and oxidative stress that are contained in four specific aims. First, we will test the hypothesis that Bim down regulation is the mechanism by which CYP2E1-overexpressing hepatocytes resist death from oxidant stress. Second, we will test the hypothesis that CYP2E1-overexpressing hepatocytes are susceptible to proapoptotic JNK/AP- 1 overactivation because of redox-dependent phosphatase inhibition. Third, we will test the hypothesis that insulin resistance mediated by oxidant-induced JNK signaling promotes hepatocyte steatosis. Fourth, we will test the hypothesis that oxidative stress in the setting of lipid accumulation stimulates JNK mediated cell death from endoplasmic reticulum stress. The ultimate goal of these investigations is to better understand the basic cellular mechanisms that lead to the development of steatosis and steatohepatitis in order to design new strategies to prevent and treat human NAFLD. Relevance to public health: NAFLD is a very prevalent liver disease which has no known treatment. Attempts to understand the mechanisms of lipid accumulation and liver injury in this disease are important to the development of new strategies for the prevention and treatment of NAFLD.
描述(由申请人提供): 在非酒精性脂肪性肝病(NAFLD)中,启动肝细胞脂质蓄积和从良性脂肪变性进展为肝细胞损伤和慢性肝病的细胞信号尚不清楚。实验性和人类NAFLD均与肝脏氧化应激沿着促氧化细胞色素P450(CYP 1A 1)酶的过度表达有关。我们的一般假设是,这种疾病中的氧化应激改变了促进肝细胞损伤发展的细胞信号级联反应。在过去的资助期内,研究已经确定了氧化应激对调节肝细胞损伤和死亡的促分裂原活化蛋白激酶(MARK)的影响。其他研究表明,CYP 2 E1过表达产生的氧化应激改变肝脏代谢,包括胰岛素敏感性和脂质蓄积。基于这些研究和额外的初步数据,我们的中心假设是,慢性氧化应激过度激活MAPK信号转导是肝脂肪变性和损伤发展的关键机制。我们建议在肝细胞和脂肪变性和氧化应激的体内模型中进行研究,以验证这一假设,这些模型包含在四个具体目标中。首先,我们将检验Bim下调是CYP 2 E1过表达肝细胞抵抗氧化应激死亡的机制这一假设。其次,我们将测试的假设,CYP 2 E1过表达的肝细胞是易受促凋亡JNK/AP- 1过度激活,因为氧化还原依赖性磷酸酶抑制。第三,我们将检验氧化剂诱导的JNK信号介导的胰岛素抵抗促进肝细胞脂肪变性的假设。第四,我们将检验在脂质积累的情况下氧化应激刺激JNK介导的内质网应激引起的细胞死亡的假设。这些研究的最终目标是更好地了解导致脂肪变性和脂肪性肝炎发展的基本细胞机制,以设计预防和治疗人类NAFLD的新策略。与公共卫生的相关性:NAFLD是一种非常普遍的肝病,目前尚无已知的治疗方法。试图了解这种疾病中脂质积聚和肝损伤的机制对于开发预防和治疗NAFLD的新策略非常重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark J Czaja其他文献

Mark J Czaja的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark J Czaja', 18)}}的其他基金

Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
连接粘附分子-A 和肠道通透性的缺陷:驱动非酒精性脂肪性肝炎的新机制的鉴定
  • 批准号:
    9913994
  • 财政年份:
    2017
  • 资助金额:
    $ 33.02万
  • 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
  • 批准号:
    9250425
  • 财政年份:
    2016
  • 资助金额:
    $ 33.02万
  • 项目类别:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
非酒精性脂肪肝的肝损伤机制
  • 批准号:
    9270797
  • 财政年份:
    2016
  • 资助金额:
    $ 33.02万
  • 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
  • 批准号:
    9115457
  • 财政年份:
    2016
  • 资助金额:
    $ 33.02万
  • 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
  • 批准号:
    9321316
  • 财政年份:
    2016
  • 资助金额:
    $ 33.02万
  • 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
  • 批准号:
    8785146
  • 财政年份:
    2014
  • 资助金额:
    $ 33.02万
  • 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
  • 批准号:
    9135052
  • 财政年份:
    2014
  • 资助金额:
    $ 33.02万
  • 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
  • 批准号:
    8923124
  • 财政年份:
    2014
  • 资助金额:
    $ 33.02万
  • 项目类别:
Modulation of Acute Liver Injury
急性肝损伤的调节
  • 批准号:
    7908374
  • 财政年份:
    2009
  • 资助金额:
    $ 33.02万
  • 项目类别:
Role of CYP2E1 in the Progression to NASH
CYP2E1 在 NASH 进展中的作用
  • 批准号:
    6744719
  • 财政年份:
    2002
  • 资助金额:
    $ 33.02万
  • 项目类别:

相似海外基金

Genome analysis-based prediction model development for response to stereotactic radiosurgery in benign brain tumors
基于基因组分析的预测模型开发,用于良性脑肿瘤立体定向放射外科治疗的反应
  • 批准号:
    23K08495
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
  • 批准号:
    10719777
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
  • 批准号:
    22KJ2498
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
良性泌尿外科、良性肾脏病学和非癌症血液学领域的学习者和领导者
  • 批准号:
    10726042
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
  • 批准号:
    10607151
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
Development of a medical device to resolve benign esophageal stricture by heating and traction
开发通过加热和牵引解决良性食管狭窄的医疗设备
  • 批准号:
    23H03765
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of benign/malignant differentiation method for thyroid follicular tumor using organoids
利用类器官开发甲状腺滤泡性肿瘤良恶性鉴别方法
  • 批准号:
    23K08075
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
p53在散发性肿瘤发生良性向恶性转变中的参与和作用机制
  • 批准号:
    10720034
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
  • 批准号:
    2306943
  • 财政年份:
    2023
  • 资助金额:
    $ 33.02万
  • 项目类别:
    Standard Grant
Towards Achieving Zero Emissions through the use of an Environmentally Benign Non-Regenerable Solvent to Capture CO2 from Large Point Source Emitters for Direct Permanent Storage in Geological Formation or Usage in Accelerated Curing of Ready-mix Con
通过使用环境友好的不可再生溶剂从大型点源排放器捕获二氧化碳,直接永久储存在地质构造中或用于预拌混凝土的加速固化,从而实现零排放
  • 批准号:
    RGPIN-2022-03431
  • 财政年份:
    2022
  • 资助金额:
    $ 33.02万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了